Cero Therapeutics to effect 1-for-100 reverse stock split

CERo Therapeutics ( CERO ) announced that its board of directors has determined to effect a one-for-one hundred reverse stock split of the Company’s common stock, par value $0.0001 per share. The reverse stock split will take effect at 12:01 a.m. Eastern Time on January 8, 2025, and the Company’s Common Stock will begin trading on a split-adjusted basis on The Nasdaq Global Market as of the opening of trading on January 8, 2025. The CUSIP number of 71902K303 will be assigned to the Company’s Common Stock when the reverse stock split becomes effective. When the reverse stock split becomes effective, every one hundred of the Company’s issued shares of Common Stock will be combined into one issued share of Common Stock, without any change to the par value per share. This will reduce the number of outstanding shares of Common Stock from approximately 260 million shares to approximately 2.6 million shares.

Stay Ahead of the Market:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on CERO: